Friday, September 27, 2024 Defining the Goals of HIV Science Through 2034 Colorized scanning electron micrograph of HIV-1 particles (teal) on a human lymphocyte (pink) grown in cell culture. Image captured at the NIAID Integrated Research Facility in Fort Detrick, Maryland. Credit: NIAID Every seven years, NIAID engages HIV research partners, community representatives, and other public health stakeholders to evaluate its HIV clinical research enterprise and inform future investments. The Institute envisions its next HIV clinical research networks maintaining support for core discovery and translational research. They must also provide multidisciplinary leadership and draw from effective partnerships at all levels to reflect an increasing interdependence across clinical practice areas and public health contexts. NIAID continues to welcome feedback on these priorities.  Learn More National Institute of Allergy and Infectious Diseases  |  National Institutes of Health

---

Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact Subscriber Help. Your subscription may be removed if you do not open our emails for a six-month period. 

This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID).

                           

---

This email was sent to edwardlorilla1986.paxforex@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107